Entries by nephstrom_admin

NEPHSTROM plenary meeting hosted by Azienda Ospedaliera Papa Giovanni XXIII Bergamo

The NEPHSTROM project team recently had another very successful and productive plenary meeting in Bergamo, Italy hosted by NEPHSTROM partner Azienda Ospedaliera Papa Giovanni XXIII Bergamo. The meeting began with a warm welcome by NEPHSTROM Coordinator Prof Tim O’Brien, NUI Galway and proceeded to a lively and productive discussion of NEPHSTROM’s work, with a particular focus on the […]

International Clinical Trials Day 2019 at the CRF Galway

The HRB Clinical Research Facility Galway in Ireland hosted a public event to celebrate International Clinical Trials Day on May 20th 2019. Exhibition stands were on display and informational meetings were held throughout the day to inform the public of all areas of clinical research being undertaken at the facility. A particular stand was dedicated to […]

NUI Galway NEPHSTROM team celebrate 3 recent publications

Congratulations to NEPHSTROM researchers at NUI Galway who have recently published three papers: “Allogeneic Mesenchymal Stromal Cells (MSCs) are of Comparable Efficacy to Syngeneic MSCs for Therapeutic Revascularization in C57BKSdb/db Mice Despite the Induction of Alloantibody”, A. Liew, C. Baustian, D. Thomas, E. Vaughan, C. Sanz-Nogués, M. Creane, X. Chen, S. Alagesan, P. Owens, J. Horan, P. Dockery, M. D. Griffin, A. Duffy, T. O’Brien. Cell Transplant. 2018 Aug;27(8):1210-1221. DOI: 10.1177/0963689718784862. […]

ISPOR 2019 award for NEPHSTROM research

NEPHSTROM-supported research by partners at Queen’s University Belfast and  Belfast Health and Social Care Trust has been identified as a semi-finalist for a Research Poster Presentation Award at ISPOR 2019 in New Orleans, USA. The research poster entitled “PUK21: RACIAL DISPARITIES IN RECORDING ANEMIA AS A COMPLICATION AMONG END-STAGE RENAL DISEASE PATIENTS” will be presented by Nga T.Q. […]

Partners at CCMI offer training workshops

Our partners at the Centre for Cell Manufacturing Ireland (CCMI) based at the National University of Ireland Galway have organized a workshop series:  “Selection, Validation and Implementation of Rapid Microbiological Methods for ATMPs“. This event will take place in Galway, Ireland on the 12th and 13th of June 2019. For more information, download the flyer here.

NEPHSTROM consortia hosted by UHBFT in Birmingham

The NEPHSTROM project team recently had another very successful and productive plenary meeting in Birmingham U.K. hosted by NEPHSTROM partner UHBFT. The meeting began with a warm welcome by NEPHSTROM Coordinator Prof Tim O’Brien, NUIG and a roundtable of introductions for any new attendees. In attendance, there were 23 delegates representing NEPHSTROM partner sites. Scientific […]

NEPHSTROM is showcased on the CORDIS website

Journalists from the European Commission have recently reported on NEPHSTROM in order to showcase the project on the CORDIS website. CORDIS is the Community Research and Development Information Service. It is the European Commission’s primary public repository and portal to disseminate information on all EU-funded research projects and their results in the broadest sense. The CORDIS news […]

NEPHSTROM public exhibition at Galway Science & Technology Festival 2018

NEPHSTROM Scientific Project Manager Dr Grace Davey amongst many other NUI Galway researchers participated at the Galway Science and Technology Festival Exhibition Day on Sunday, 25 November 2018. The interactive NEPHSTROM display in the Bailey Allen Hall of the National University of Ireland Galway exhibited models and props which helped to explain diabetes and its complications and […]

NEPHSTROM presents at American Society of Nephrology Kidney Week, San Diego

NEPHSTROM PIs Matthew Griffin of the National University of Ireland, Galway and Norberto Perico of the Istituto di Ricerche Farmacologiche Mario Negri (IRFMN) were involved in presentations at the American Society of Nephrology Kidney Week, San Diego, USA. The meeting which ran from the 23-28 October 2018 is the largest international conference for Nephrology. Norberto […]

NEPHSTROM Clinical Trial Underway at Four Locations

“We are pleased the NEPHSTROM clinical trial has commenced and that randomized diabetic patients with kidney disease whose previous therapies failed now are receiving ORBCEL-M™ immunotherapy,” said Dr Larry Couture, CEO of Orbsen Therapeutics. “The study may be a breakthrough moment for patients with end-stage renal disease caused by diabetes.” Orbsen Therapeutics, a biotechnology company focused […]